Bibliography
- RhOne-Poulenc SA. http://drugnet.com. Company report.
- RhOne-Poulenc Rorer, 'Value through innovation'. (1996). Summary report.
- MARTIN P, THOMAS SM: The development of gene ther- apy in Europe and the United States: a comparative analysis. Report prepared for the European Commis-sion, SPRU, STEEP. (1996) 5:148. (Special Report).
- BONNEKOH B et al: J. Invest. Dermatol. (1998) 6:867–871.
- PARR MJ et al: J. Neurovirol. (1998) 4:194–203.
- GEDDES BJ: Long-term gene therapy in the CNS: rever- sal of hypothalamic diabetes insipidus in the Brattle-boro rat by using an adenovirus expressing arginine vasopressin. Major Med. (1997) 3:1402–1404.
- LAPCHAK PA et al: Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease. Brain Res. (1997) 777:153-160. Julian F Burkel, Nick Simmonds2 & Sandy M Thomas3,4t